UPDATE Long-Term Follow-up in Babies Born with ‘Bubble Boy Disease’ Still Seem Cured Between 2012 and 2017, 62 babies and toddlers were treated with a genetic therapy for severe combined immunodeficiency, known colloquially as the “Bubble Boy disease.” In 2021, GNN reported on the results of the trial—that by 2019, 95%, or all but two of the young patients, showed complete immune system reconstruction. Now, the long-term follow-up […] The post UPDATE Long-Term Follow-up in Babies Born with ‘Bubble Boy Disease’ Still Seem Cured appeared first on Good News Network.

UPDATE Long-Term Follow-up in Babies Born with ‘Bubble Boy Disease’ Still Seem Cured: Between 2012 and 2017, 62 babies and toddlers were treated with a genetic therapy for severe… @goodnewsnetwork.org #BubbleBoyDisease #GeneticTherapy #ImmuneSystem #SevereCombinedImmunodeficiency #PediatricHealth

Genetic Therapy Cuts Cholesterol by Nearly 50% in Groundbreaking Study Polypurine hairpins are used to inhibit PCSK9 expression. When cholesterol levels in the blood rise too high, a condition known as hypercholesterolemia can develop, damaging arteries and threatening heart...

Genetic Therapy Cuts Cholesterol by Nearly 50% in Groundbreaking Study #Science #HealthandMedicine #GeneticsandGenomics #GeneticTherapy #Cholesterol #HealthInnovations

Lysosomal Acid Lipase Deficiency Market Size, Report 2035 Lysosomal Acid Lipase Deficiency Market to reach USD 2.64 Billion by 2035, growing at 9.72% CAGR. Explore size, share, companies, segments & forecast 2025–2035.

🧬 The LAL Deficiency Market evolves with breakthroughs in enzyme replacement therapies. Full study: www.marketresearchfuture.com/reports/lyso... #RareDisease #GeneticTherapy #PharmaResearch

From birth to gene-edited in 6 months: Custom therapy breaks speed limits The N-of-1 accomplishment provides a template for swift, personalized genetic therapies.

A custom CRISPR therapy developed in six months for a newborn shows the speed of medical innovation. How far can this go in treating genetic diseases? #Biotech #CRISPR #GeneticTherapy

Breakthrough gene editing offers hope for sickle cell anemia patients at Johns Hopkins University Researchers announce breakthrough gene editing and stem cell treatments curing sickle cell anemia.

A groundbreaking session in Maryland has unveiled revolutionary treatments for sickle cell anemia, igniting hope for families who have long suffered from this devastating disease.

Learn more here!

#MD #CitizenPortal #GeneticTherapy #MarylandSickleCell #PatientAdvocacy #HealthInnovation